vs
i3 Verticals, Inc.（IIIV）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
i3 Verticals, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.5倍（$52.7M vs $35.5M），i3 Verticals, Inc.净利率更高（0.9% vs -304.2%，领先305.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -14.6%），i3 Verticals, Inc.自由现金流更多（$13.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -4.7%）
Prusa i3是捷克Prusa Research公司生产的熔融沉积成型3D打印机系列，以Original Prusa i3为注册商标推出，同时也是RepRap项目的组成部分。2016年该系列就被评为全球使用率最高的3D打印机，最早由Josef Průša在2012年完成设计，2015年正式推出商用套件版本，目前最新型号同时提供散件套件和原厂组装版本，具备性价比高、易操作的优势。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
IIIV vs RXRX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $35.5M |
| 净利润 | $484.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 3.1% | -304.8% |
| 净利率 | 0.9% | -304.2% |
| 营收同比 | -14.6% | 681.7% |
| 净利润同比 | -76.5% | 39.6% |
| 每股收益（稀释后） | $0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $52.7M | $35.5M | ||
| Q3 25 | $46.0M | $5.2M | ||
| Q2 25 | $51.9M | $19.2M | ||
| Q1 25 | $63.1M | $14.7M | ||
| Q4 24 | $52.2M | $4.5M | ||
| Q3 24 | $32.0M | $26.1M | ||
| Q2 24 | $46.2M | $14.4M | ||
| Q1 24 | $58.0M | $13.8M |
| Q4 25 | $484.0K | $-108.1M | ||
| Q3 25 | $3.1M | $-162.3M | ||
| Q2 25 | $12.9M | $-171.9M | ||
| Q1 25 | $-154.0K | $-202.5M | ||
| Q4 24 | $2.1M | $-178.9M | ||
| Q3 24 | $117.9M | $-95.8M | ||
| Q2 24 | $-7.5M | $-97.5M | ||
| Q1 24 | $1.9M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 3.1% | -304.8% | ||
| Q3 25 | 3.2% | -3327.6% | ||
| Q2 25 | -9.3% | -916.8% | ||
| Q1 25 | 8.0% | -1297.9% | ||
| Q4 24 | 3.9% | -4042.4% | ||
| Q3 24 | 10.6% | -377.1% | ||
| Q2 24 | -2.8% | -697.4% | ||
| Q1 24 | 3.4% | -698.4% |
| Q4 25 | 0.9% | -304.2% | ||
| Q3 25 | 6.7% | -3135.3% | ||
| Q2 25 | 24.8% | -894.2% | ||
| Q1 25 | -0.2% | -1373.3% | ||
| Q4 24 | 3.9% | -3935.5% | ||
| Q3 24 | 368.2% | -367.5% | ||
| Q2 24 | -16.3% | -676.6% | ||
| Q1 24 | 3.2% | -662.4% |
| Q4 25 | $0.02 | $-0.17 | ||
| Q3 25 | $0.14 | $-0.36 | ||
| Q2 25 | $0.50 | $-0.41 | ||
| Q1 25 | $0.00 | $-0.50 | ||
| Q4 24 | $0.08 | $-0.56 | ||
| Q3 24 | $4.93 | $-0.34 | ||
| Q2 24 | $-0.32 | $-0.40 | ||
| Q1 24 | $0.08 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $358.5M | $1.1B |
| 总资产 | $595.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $37.5M | $743.3M | ||
| Q3 25 | $66.7M | $659.8M | ||
| Q2 25 | $55.5M | $525.1M | ||
| Q1 25 | $7.7M | $500.5M | ||
| Q4 24 | $85.6M | $594.4M | ||
| Q3 24 | $86.5M | $427.6M | ||
| Q2 24 | $9.7M | $474.3M | ||
| Q1 24 | $3.1M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $0 | $11.9M | ||
| Q2 25 | $0 | $14.2M | ||
| Q1 25 | $12.0M | $16.4M | ||
| Q4 24 | $26.2M | $19.0M | ||
| Q3 24 | $26.2M | $20.5M | ||
| Q2 24 | $374.1M | $22.9M | ||
| Q1 24 | $369.6M | — |
| Q4 25 | $358.5M | $1.1B | ||
| Q3 25 | $389.6M | $1.0B | ||
| Q2 25 | $383.3M | $919.1M | ||
| Q1 25 | $385.2M | $933.9M | ||
| Q4 24 | $375.0M | $1.0B | ||
| Q3 24 | $379.7M | $524.6M | ||
| Q2 24 | $249.7M | $584.4M | ||
| Q1 24 | $249.3M | $401.2M |
| Q4 25 | $595.9M | $1.5B | ||
| Q3 25 | $638.4M | $1.4B | ||
| Q2 25 | $623.3M | $1.3B | ||
| Q1 25 | $646.4M | $1.3B | ||
| Q4 24 | $726.2M | $1.4B | ||
| Q3 24 | $730.7M | $726.5M | ||
| Q2 24 | $861.7M | $775.9M | ||
| Q1 24 | $625.8M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.00× | 0.01× | ||
| Q2 25 | 0.00× | 0.02× | ||
| Q1 25 | 0.03× | 0.02× | ||
| Q4 24 | 0.07× | 0.02× | ||
| Q3 24 | 0.07× | 0.04× | ||
| Q2 24 | 1.50× | 0.04× | ||
| Q1 24 | 1.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $13.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 26.2% | -133.1% |
| 资本支出强度资本支出/营收 | 0.6% | 3.5% |
| 现金转化率经营现金流/净利润 | 29.18× | — |
| 过去12个月自由现金流最近4个季度 | $6.5M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $14.1M | $-46.1M | ||
| Q3 25 | $14.0M | $-117.4M | ||
| Q2 25 | $7.4M | $-76.4M | ||
| Q1 25 | $-27.1M | $-132.0M | ||
| Q4 24 | $11.5M | $-115.4M | ||
| Q3 24 | $15.1M | $-59.2M | ||
| Q2 24 | $8.1M | $-82.2M | ||
| Q1 24 | $10.7M | $-102.3M |
| Q4 25 | $13.8M | $-47.3M | ||
| Q3 25 | $13.5M | $-117.6M | ||
| Q2 25 | $6.8M | $-79.6M | ||
| Q1 25 | $-27.6M | $-133.8M | ||
| Q4 24 | $11.0M | $-116.7M | ||
| Q3 24 | $14.6M | $-63.8M | ||
| Q2 24 | $7.2M | $-83.4M | ||
| Q1 24 | $9.9M | $-109.0M |
| Q4 25 | 26.2% | -133.1% | ||
| Q3 25 | 29.5% | -2272.5% | ||
| Q2 25 | 13.1% | -413.9% | ||
| Q1 25 | -43.8% | -907.4% | ||
| Q4 24 | 21.1% | -2567.7% | ||
| Q3 24 | 45.6% | -244.6% | ||
| Q2 24 | 15.6% | -578.5% | ||
| Q1 24 | 17.1% | -789.9% |
| Q4 25 | 0.6% | 3.5% | ||
| Q3 25 | 0.9% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | 0.8% | 12.4% | ||
| Q4 24 | 0.9% | 28.6% | ||
| Q3 24 | 1.7% | 17.5% | ||
| Q2 24 | 1.9% | 8.2% | ||
| Q1 24 | 1.4% | 48.2% |
| Q4 25 | 29.18× | — | ||
| Q3 25 | 4.52× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.59× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIV
| License And Service | $35.7M | 68% |
| Proprietary Payments Revenue | $14.5M | 27% |
| Other Revenue | $2.5M | 5% |
RXRX
暂无分部数据
